Pterostilbene is a close chemical relative of resveratrol – two methoxy groups instead of two hydroxyl groups – and that small structural difference gives it meaningfully better oral bioavailability, roughly 80% absorption versus about 30% for resveratrol. But the human clinical picture isn’t a simple “pterostilbene wins”: the one placebo-controlled trial that tested it in adults with high cholesterol found it significantly raised LDL cholesterol at higher doses, a finding worth knowing before treating better absorption as automatically better.
Table of Contents
- What Pterostilbene Actually Is
- Why It Absorbs Better Than Resveratrol
- What the Human Safety Trial Found
- The LDL Cholesterol Finding You Should Know
- Cognitive Claims: What’s Actually Been Tested in Humans
- Which One Should You Take?
What Pterostilbene Actually Is
Pterostilbene is a naturally occurring stilbene compound found in blueberries and, in smaller amounts, in grapes – chemically it’s a dimethylated analog of resveratrol, meaning it shares the same core structure but with methoxy groups in place of two of resveratrol’s hydroxyl groups. That substitution is a small change with a real functional consequence: it makes the molecule more lipophilic (fat-soluble), which is the main reason it’s absorbed and metabolized differently in the body.
Why It Absorbs Better Than Resveratrol
The lipophilicity difference translates into a real bioavailability gap. Pterostilbene reaches roughly 80% oral bioavailability, compared to approximately 30% for resveratrol, and it also shows greater penetrance across the blood-brain barrier. Resveratrol is notorious for extremely fast first-pass liver metabolism – most of an oral dose is glucuronidated and sulfated within an hour of absorption – and pterostilbene’s methoxy groups make it more resistant to that same rapid clearance.
What “better absorbed” does and doesn’t mean: higher bioavailability means more of the compound reaches circulation intact. It does not, on its own, mean a stronger biological effect – that depends on what the compound does once it’s there, which is a separate, and much less studied, question for pterostilbene in humans.
What the Human Safety Trial Found
The main human data on pterostilbene comes from a randomized, double-blind, placebo-controlled trial in 80 adults with hypercholesterolemia (high cholesterol), published in the Journal of Toxicology (Riche et al., 2013). Participants took either placebo, 50 mg pterostilbene twice daily, 125 mg twice daily, or 50 mg pterostilbene plus 100 mg grape extract twice daily, for roughly 6-8 weeks. The trial’s conclusion on safety was clear: no adverse effects on liver, kidney, or glucose markers, and the authors concluded pterostilbene is generally safe at doses up to 250 mg per day, with only mild, infrequent gastrointestinal effects (nausea, dyspepsia, diarrhea) reported.
The LDL Cholesterol Finding You Should Know
This is the finding a “no fluff” comparison can’t skip. In that same trial, pterostilbene taken alone significantly increased LDL cholesterol – by 17.1 mg/dL (p=0.001) at the higher dose – in this hypercholesterolemic study population. When combined with grape extract at the lower dose, the LDL increase was attenuated. This was an efficacy finding, not a safety failure (the trial’s safety conclusion stands), but it’s the opposite of what you’d want if cholesterol management is part of why you’re considering a stilbene supplement in the first place, and it’s not a result resveratrol itself has shown in comparable research.
This finding hasn’t been widely replicated with larger trials, and it was measured specifically in people who already had high cholesterol going in – but it’s the actual clinical trial data available, not a marketing claim, and it belongs in any honest comparison.
Cognitive Claims: What’s Actually Been Tested in Humans
Pterostilbene is frequently marketed around cognitive and neuroprotective benefits, largely on the strength of its better blood-brain barrier penetrance and a body of rodent studies showing antioxidative effects in brain tissue. What’s important to know: no clinical trials have confirmed cognitive benefits in humans. The human trials that exist have focused on cardiovascular markers (the cholesterol trial above) and other non-cognitive endpoints – cognitive benefit in people remains an extrapolation from animal data, not an established human finding.
Which One Should You Take?
Neither compound has a clean “wins on everything” case. Pterostilbene absorbs more efficiently and crosses into the brain more readily, but the one relevant human efficacy trial found an LDL cholesterol increase that runs counter to what most people taking a longevity supplement are hoping for. Resveratrol has a far larger body of human clinical research behind it – including the dosage research covered in our full guide – even though its oral bioavailability is lower. If you’re weighing the two, what matters isn’t “which absorbs better” alone, but which compound has research actually matching the outcome you’re targeting.
Whichever you land on, the research only applies if what you’re taking is the real, verified compound – pure resveratrol at a tested purity, not a diluted or mislabeled product riding on the name. Compare Mega Resveratrol’s trans-resveratrol and trans-pterostilbene capsules – both third-party tested – if you’re deciding between the two.
Frequently Asked Questions
Is pterostilbene stronger than resveratrol? Not in a simple sense. Pterostilbene is better absorbed (roughly 80% versus 30% oral bioavailability), but “better absorbed” isn’t the same as “more effective” – the one human efficacy trial on pterostilbene found a cholesterol effect that isn’t a positive one.
Does pterostilbene raise cholesterol? In the one placebo-controlled human trial available, pterostilbene taken alone significantly increased LDL cholesterol at higher doses in adults who already had high cholesterol. Combining it with grape extract reduced this effect. This hasn’t been tested in a broader, non-hypercholesterolemic population.
Is pterostilbene safe? The same clinical trial that found the LDL effect also concluded pterostilbene is generally safe at doses up to 250 mg per day, with no adverse effects on liver, kidney, or glucose markers, and only mild, infrequent GI side effects.
Does pterostilbene improve memory or brain function? No human clinical trials have confirmed this. The claim comes from rodent studies and pterostilbene’s known ability to cross the blood-brain barrier more readily than resveratrol – it’s a plausible hypothesis, not an established human finding.
Can you take pterostilbene and resveratrol together? Some products combine them, and the clinical trial above tested pterostilbene alongside grape extract specifically to offset the LDL effect. There’s no dedicated human trial on combining pterostilbene with resveratrol itself, so any combination claim should be treated as unproven rather than confirmed.
Conclusion
The honest comparison isn’t “pterostilbene is the upgraded resveratrol” – that’s an absorption-only argument that skips the one human efficacy trial available, which found a cholesterol effect worth weighing seriously. Pterostilbene absorbs better and reaches the brain more readily; resveratrol has a much larger, longer-standing body of human research behind it. Which one fits depends on what you’re actually trying to achieve, not which one sounds more advanced.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare professional before starting any new supplement, particularly if you have high cholesterol or are taking cholesterol-affecting medication.
Resources cited:
- Riche DM, et al. “Analysis of Safety from a Human Clinical Trial with Pterostilbene.” Journal of Toxicology, 2013. Wiley Online Library / PMC. https://onlinelibrary.wiley.com/doi/10.1155/2013/463595
- ClinicalTrials.gov. “Effect of Pterostilbene on Cholesterol, Blood Pressure and Oxidative Stress.” NCT01267227. https://clinicaltrials.gov/study/NCT01267227
- Alzheimer’s Drug Discovery Foundation, Cognitive Vitality. “Pterostilbene.” (Bioavailability comparison, cholesterol trial summary, cognitive evidence review.) https://www.alzdiscovery.org/uploads/cognitive_vitality_media/Pterostilbene_UPDATE_(supplement).pdf
